Search Within

Gregory J Riely

Formats
  1. Journal Article (295)
  2. Meeting Abstract (265)
  3. Book Section (16)
  4. Guidelines (15)
  5. Conference Paper (4)
  6. Review (4)
  7. Editorial (3)
  8. Book Whole (1)
  9. Correspondence (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (605)
  2. Solid Tumor Oncology Division (605)
  3. Thoracic Oncology (605)
  4. Department of Pathology and Laboratory Medicine (262)
  5. GSK Faculty (248)
  6. Human Oncology and Pathogenesis Program (223)

More Groups

People
  1. Mark Kris (222)
  2. Marc Ladanyi (188)
  3. Helena Yu (108)
  4. Maria Arcila (85)
  5. Vincent Miller (79)
  6. Charles Rudin (76)

More People

Years
  1. 2025 (9)
  2. 2024 (25)
  3. 2023 (45)
  4. 2022 (39)
  5. 2021 (41)
  6. 2020 (29)

More Years

Publications
  1. Journal of Clinical Oncology (157)
  2. Journal of Thoracic Oncology (113)
  3. Clinical Cancer Research (46)
  4. Annals of Oncology (32)
  5. Journal of the National Comprehensive Cancer Network (26)
  6. Cancer Research (14)

More Publications

Publishers
  1. American Society of Clinical Oncology (175)
  2. Elsevier Inc. (137)
  3. American Association for Cancer Research (77)
  4. Oxford University Press (39)
  5. Harborside Press (26)
  6. Elsevier Science, Inc. (23)

More Publishers

Results (605)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Characterization and management of mobocertinib (TAK-788) induced skin toxicity in patients with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) who previously received platinum chemotherapy
    Meeting Abstract

    Yang, J. C. H.; Ramalingam, S. S.; Kim, T. M.; Kim, S. W.; Riely, G. J.; Mekhail, T.; Nguyen, D.; Garcia Campelo, M. R.; Felip, E.; Bazhenova, L.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Characterization of GI toxicities and their impact on efficacy in patients (pts) with EGFR exon 20 insertion+ (ex20ins+) non-small cell lung cancer (NSCLC) treated with mobocertinib (TAK-788) who previously received platinum chemotherapy
    Meeting Abstract

    Nguyen, D.; Ramalingam, S. S.; Spira, A.; Riely, G. J.; Kim, T. M.; Yang, J. C. H.; Piotrowska, Z.; Garcia Campelo, M. R.; Felip, E.; Bazhenova, L.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Genomic characterization and clinical outcomes of patients (pts) with metastatic colorectal cancer (mCRC) with peritoneal metastases (PM) in AACR project GENIE
    Meeting Abstract

    Sanz Garcia, E.; Riely, G. J.; Lepisto, E. M.; LeNoue-Newton, M. L.; Warner, J. L.; Sweeney, S. M.; McCarthy, C. G.; Weiss, J.; Yu, C.; Voon, P. J.; more...
    Annals of Oncology (2021)

    Fulltext@MSK | Save
  • Clinicopathological and molecular characteristics, treatment patterns, and outcomes in patients with KRAS p.G12C-mutated metastatic non-small cell lung cancer (NSCLC) in the AACR Project GENIE database
    Meeting Abstract

    Ricciuti, B.; Wang, C.; Rizvi, H.; Egger, J.; LeNoue-Newton, M.; Holt, M.; Aggarwal, S.; Tu, H.; Hsu, H.; Wang, X.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Defining real-world recurrence in the AACR Project GENIE Biopharma Collaborative Data
    Meeting Abstract

    Lavery, J. A.; Brown, S.; Lepisto, E.; Lenoue-Newton, M. L.; McCarthy, C.; Rizvi, H.; Yu, C.; Kehl, K. L.; Sweeney, S. M.; Rudolph, J. E.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Smarca4 inactivation promotes lineage-specific transformation and early metastatic features in the lung
    Meeting Abstract

    Concepcion, C. P.; Ma, S.; LaFave, L. M.; Bhutkar, A.; Liu, M.; DeAngelo, L. P.; Kim, J. Y.; Del Priore, I.; Schoenfeld, A. J.; Kartha, V. K.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Ignoring left truncation in overall survival within real-world genomic-phenomic data leads to inflated survival estimates
    Meeting Abstract

    Brown, S.; Lavery, J. A.; Lepisto, E. M.; McCarthy, C.; Rizvi, H.; Yu, C.; Kehl, K. L.; Sweeney, S. M.; Rudolph, J. E.; Schultz, N.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Mechanisms of acquired resistance to KRAS G12C inhibition in cancer
    Meeting Abstract

    Awad, M.; Liu, S.; Arbour, K.; Zhu, V.; Johnson, M.; Heist, R.; Patil, T.; Riely, G.; Jacobson, J.; Dilly, J.; more...
    Cancer Research (2021)

    Fulltext@MSK | Save
  • MYC promotes tyrosine kinase inhibitor resistance in ROS1 fusion positive lung cancers
    Meeting Abstract

    Iyer, S. R.; Odintsov, I.; Schoenfeld, A. J.; Sato, H.; Siau, E.; Drilon, A.; Riely, G. J.; Somwar, R.; Ladanyi, M.; Davare, M. A.
    Cancer Research (2021)

    Fulltext@MSK | Save
  • Correlation between surrogate end points and overall survival in a multi-institutional clinicogenomic cohort of patients with non-small cell lung or colorectal cancer
    Journal Article

    Kehl, K. L.; Riely, G. J.; Lepisto, E. M.; Lavery, J. A.; Warner, J. L.; LeNoue-Newton, M. L.; Sweeney, S. M.; Rudolph, J. E.; Brown, S.; Yu, C. L.; more...
    JAMA Network Open (2021)

    Fulltext@MSK | Save